Handan First Hospital

Running trials

• Not yet recruiting

  A Study Evaluating Safety and Tolerability of Switching From Semaglutide to Zovaglutide in Adults With Obesity (HORIZON-SWITCH-SZ)

  NCT07812597· Phase 2· Source

• Active, not recruiting

  A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)

  NCT07230119· Phase 3· Source

• Active, not recruiting

  Efficacy and Safety of ZT006 in Overweight and Obese Participants

  NCT07230132· Phase 2· Source

• Not yet recruiting

  Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer

  NCT07007286· Source

• Recruiting

  Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)

  NCT06548971· Phase 3· Source

• Active, not recruiting

  A Study of Telitacicept for IgA Nephropathy (TELIGAN)

  NCT05799287· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hepatitis B1 recruiting
• Liver and biliary tract cancer1 recruiting
• Obesity1 recruiting
• Stroke1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects

  NCT06738979· Phase 3· Source

• Completed

  A Study of ZT002 Injection With Subjects With Overweight or Obesity

  NCT07020884· Phase 2· Source

• Completed

  Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

  NCT06415773· Phase 3· Source

• Completed

  Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

  NCT06353347· Phase 3· Source

• Completed

  Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes

  NCT06350890· Phase 3· Source

• Completed

  Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)

  NCT05439356· Phase 3· Source